Data / Form D filings / Elixir Pharmaceuticals, Inc.
Elixir Pharmaceuticals, Inc.: Form D filing
Elixir Pharmaceuticals, Inc., a pharmaceuticals company in Cambridge, MA, filed a Form D with the SEC in 2009. The latest, on May 28, 2009, reports $12 million sold of a $25 million offering to 36 investors.
Find out what Elixir Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 12 EMILY STREET, Cambridge, MA, 02139
- Phone
- (617) 995-7000
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- De
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1175784
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 28, 2009 | New notice | $25,000,000 | $11,994,995 | $13,005,005 | 36 | May 15, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Vernon Cassin | Director | |
| Dion Madsen | Director | |
| Robert Kriebel | Executive Officer | |
| Karen Roberts | Executive Officer | |
| Kenneth Greenberg | Director | |
| Ansbert Gadicke | Director | |
| Vaughn M. Kailian | Director | |
| Peter S. DiStefano | Executive Officer | |
| Paul M. Martha | Executive Officer, Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- BridgeHealth Pharmaceuticals, Inc. $3.5 million · Nov 5, 2026
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of May 25, 2009 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Elixir Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.